John D Grabenstein
Affiliation: Merck Research Laboratories
- Pneumococcal polysaccharide 23-valent vaccine: long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adultsJohn D Grabenstein
Merck Vaccines, 770 Sumneytown Pike, WP97 B364, West Point, PA 19426, USA john
Vaccine 30:4435-44. 2012..PPSV23 is a broad-spectrum public-health tool to help prevent serious pneumococcal diseases across the adult lifespan...